Thursday, September 10th, 2015 | 6:30-9:00 PM|
InnoSpring Inc., Suite 107,
2901 Tasman Drive, Santa Clara, CA 95054
Keynote Speaker -
Ruchita Sinha Director, GE Ventures
Patrick Ruane SVP of R&D, Chrono Therapeutics
David Matly VP of BD, Chrono Therapeutics
6:30 pm Check in, & Networking
7:00 pm Introduction
7:15 pm Keynote from Chrono Therapeutics
8:00 pm Keynote from GE Ventures
8:45 pm Adjourn
Early Bird: $0 (Only for the first 20 audience) Regular: $10
The excitement of mHealth continues. We started with the 2015 mHealth Trends in the first quarter and provided a platform for healthcare startups to present and demonstrate their exciting ideas, products and technology in the first half of the year. In this session, we will focus on the innovation in wellness and how this can help people changing to a healthier lifestyle. What are the new ideas and technology that can help people change their behavior like stop smoking, eat healthier, etc. What would be the market opportunities and the business model? How can this attract the investor and what would the VCs see these as the opportunities or just another technology in digital health?
Please come and join us for another exciting and educational night.
Director, GE Ventures
Ruchita Sinha is a Director on the GE Ventures team based in Menlo Park, CA. In this role, Ruchita is involved in investments and partnerships with healthcare startups. She specializes in innovative partnership models that enable startups to scale and drive growth for GE. Ruchita oversees GE’s investments in Caremerge, HeartFlow, CheckCap, Nanosonics and also serves as an advisor to StartUp Health and Rock Health. Ruchita has more than 15 years healthcare experience in pharma, biotech, medical devices, and healthcare IT. Prior to joining GE, Ruchita was a Director in Pfizer’s Corporate Strategy & Portfolio Management group, and a management consultant with LEK Consulting. Ruchita started her career with Maxygen, an early stage biotech company.
She holds an MBA from the University of Chicago, an MS in Cellular and Molecular Biology from the University of Wisconsin-Madison, and a BS in Biochemistry from Mount Holyoke College.
Senior Vice President of R&D, Chrono Therapeutics
Dr. Ruane has nearly 2 decades of experience in drug delivery for combination medical devices. He most recently served as Vice President of R&D at CV Ingenuity (acquired by Covidien) and has held various positions in R&D at Xtent, Cook Group and Navigant Biotechnologies.
Dr. Ruane received his primary degrees in Chemistry from The Galway-Mayo Institute of Technology and Trinity College Dublin, his Ph.D. from University College Dublin and Post-Docs at University of Toronto and The Johns Hopkins University. He is published extensively in both the academic and patent literature.